Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

<B><I>BREAKING NEWS:</b></i> <b>Merck Settles Vioxx Case for $950 Million</b>

Nate Raymond

Merck &amp; Co., Inc. became the latest healthcare company to strike a major settlement with the Justice Department on Nov. 22, agreeing to pay $950 million to resolve criminal and civil charges stemming from its marketing of the painkiller Vioxx.

Drug & Device News

ALM Staff & Law Journal Newsletters

News you may have missed.

Features

Verdicts

ALM Staff & Law Journal Newsletters

Analysis of recent key rulings.

Med Mal News

ALM Staff & Law Journal Newsletters

All the latest you need to know.

Features

Effective Use of Physician Assistants

Barry B. Cepelewicz & Richard J. Nealon

The use of P.A.s presents a number of medico-legal issues for a practice that must be considered, both by medical practitioners and their legal counsel. Failure to do so could result in increased liability exposure for the physician and the practice.

Features

Hospital-Acquired Infections Are on the Rise

Brandon Swartz

Last month, we discussed the rising incidence of deaths related to hospital-acquired infections. With the accompanying publicity of the dangers MRSA infection poses, it is not surprising that litigation in this area is also on the rise.

The Future of Medical Malpractice Claims in a 'Tele-World'

Elizabeth A. Syer

The pros and cons of "telemedicine," and what it means to the med mal practitioner.

Verdicts

ALM Staff & Law Journal Newsletters

In-depth analysis of an important ruling.

Features

Drug & Device News

ALM Staff & Law Journal Newsletters

Recent news of interest to you and your practice.

Med Mal News

ALM Staff & Law Journal Newsletters

A recent item of interest.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • Revised Proposal: Understanding the Interagency Statement on Complex Structured Finance Activities
    Many U.S. financial institutions that have participated in equipment leasing transactions (particularly in the large-ticket and municipal markets) in the last 20 years will be keenly aware that as the structures grew ever more complicated, Congress and the federal regulatory agencies grew intensely interested. Whether the institution had a major role in the transaction or simply provided a service, some degree of scrutiny could be expected, often in conjunction with a tax audit of its client. The risks to financial institutions from participating in complex structured finance transactions of all types became a source for concern for banking and securities regulators. The principal federal regulators responded in 2004 with a proposal that financial institutions investigate, and bear responsibility for evaluating, the legal, tax, and accounting basis of their clients' complex structured finance transactions. The goal: to limit the institutions' own credit, legal, and reputational risk from such participation.
    Read More ›